AB
LRMR icon

Amalgamated Bank’s Larimar Therapeutics LRMR Stock Holding History

Amalgamated Bank’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,527
Closed -$6K – 2300
2025
Q4 		$6K Buy
1,527
+75
+5% +$292 ﹤0.01% 2651
2025
Q3 		$5K Hold
1,452
– – ﹤0.01% 2773
2025
Q2 		$4K Hold
1,452
– – ﹤0.01% 2848
2025
Q1 		$3K Buy
1,452
+587
+68% +$1.85K ﹤0.01% 2789
2024
Q4 		$3K Hold
865
– – ﹤0.01% 2855
2024
Q3 		$6K Hold
865
– – ﹤0.01% 2705
2024
Q2 		$6K Hold
865
– – ﹤0.01% 2688
2024
Q1 		$7K Sell
865
-1,372
-61% -$10.7K ﹤0.01% 2588
2023
Q4 		$10K Sell
2,237
-257
-10% -$867 ﹤0.01% 2860
2023
Q3 		$10K Hold
2,494
– – ﹤0.01% 2893
2023
Q2 		$8K Buy
+2,494
New +$10.2K ﹤0.01% 2976

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Amalgamated Bank's LRMR Position: Q1 2026 in Review

Amalgamated Bank sold out of Larimar Therapeutics (LRMR) in Q1 2026, closing a stake of 1,527 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in LRMR in Q2 2023 and held it in 11 quarters. The position peaked at $10K in Q4 2023. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Amalgamated Bank reported no remaining Larimar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,527 Larimar Therapeutics shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in Larimar Therapeutics in Q2 2023 and held it in 11 quarters.
  • Amalgamated Bank's Larimar Therapeutics position peaked at $10K in Q4 2023.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.